Degnan Chris Insider Trades & Stock Holdings

Chief Financial Officer · UroGen Pharma Ltd. · Latest filing Oct 8, 2026

Degnan Chris, Chief Financial Officer at UroGen Pharma Ltd. has 1 Form 4 trade on file since Oct 8, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($80.79K), net -$80.79K. Latest filing: disposed of 2.20K shares of $URGN on Oct 8, 2026 at $36.69.

Trades on file

1

Open-market bought

$0

Open-market sold

$80.79K

Net open-market

-$80.79K

Latest filing

Oct 8, 2026

All insider trades by Degnan Chris

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 8, 2026	$URGN	Sell (Open-market sale)	2.20K	$36.69	$80.79K			-1.0%			Chief Financial Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Degnan Chris traded

• $URGN

Frequently asked questions

Has Degnan Chris been buying or selling stock?

Degnan Chris has 0 open-market purchases and 1 open-market sale on file, net -$80.79K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Degnan Chris's latest insider trade?

disposed of 2.20K shares of $URGN on Oct 8, 2026 at $36.69.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.